Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCD-Haplo: Haploidentical Stem Cell Transplant for Sickle Cell Disease
NCT02013375Phase 2Terminated
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in sickle cell disease (SCD). Started Apr 2014; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02013375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013375.